VRTX icon

Vertex Pharmaceuticals

386 hedge funds and large institutions have $16.5B invested in Vertex Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 134 increasing their positions, 161 reducing their positions, and 57 closing their positions.

Holders
386
Holders Change
-17
Holders Change %
-4.22%
% of All Funds
11.21%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
40
Increased
134
Reduced
161
Closed
57
Calls
$388M
Puts
$319M
Net Calls
+$69.6M
Net Calls Change
-$81.1M
Name Market Value Shares Shares
Change
Shares
Change %
YMRC
426
Yorktown Management & Research Company
Virginia
-2,900 Closed
GCA
427
Greenwood Capital Associates
South Carolina
-2,845 Closed
BSW
428
Buckingham Strategic Wealth
Missouri
-2,825 Closed
BF
429
BOK Financial
Oklahoma
-2,681 Closed
Fuller & Thaler Asset Management
430
Fuller & Thaler Asset Management
California
-1,700 Closed
BG
431
Bollard Group
Massachusetts
-1,280 Closed
ICRM
432
Insight Capital Research & Management
California
-1,209 Closed
LSV Asset Management
433
LSV Asset Management
Illinois
-950 Closed
OAM
434
Orinda Asset Management
California
-800 Closed
HR
435
Howe & Rusling
New York
-247 Closed
DBT
436
Dubuque Bank & Trust
Iowa
-205 Closed
CA
437
CapWealth Advisors
Tennessee
-100 Closed
CGT
438
Capital Guardian Trust
California
-55 Closed
TIM
439
Tortoise Investment Management
New York
-40 Closed
Jones Financial Companies
440
Jones Financial Companies
Missouri
-26 Closed
ECM
441
ETrade Capital Management
Virginia
-9 Closed
HCC
442
Hirtle Callaghan & Co
Pennsylvania
-6 Closed
Victory Capital Management
443
Victory Capital Management
Texas
-4 Closed
Capital Fund Management (CFM)
444
Capital Fund Management (CFM)
France
ID
445
Integral Derivatives
New York
GTC
446
Ghost Tree Capital
New York